Quantum BioPharma Ltd. Basic Earnings Loss Per Share From Discontinued Operations
Quantum BioPharma Ltd. (QNTM) reported Basic Earnings Loss Per Share From Discontinued Operations of $0.00 per share for the 12-month period ending 2024-12-31, per its 20-F/A filed 2025-03-31.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations · last filed 2025-03-31
| Period end | Basic Earnings Loss Per Share From Discontinued Operations 12 month | Basic Earnings Loss Per Share From Discontinued Operations 12 month as first filed |
|---|---|---|
| 2024-12-31 | $0.00 20-F/A · filed 2025-03-31 | |
| 2023-12-31 | $0.00 20-F/A · filed 2025-03-31 | |
| 2022-12-31 | $5.20 20-F/A · filed 2025-03-31 | $0.08 20-F · filed 2023-03-31 |
| 2021-12-31 | -$0.04 20-F · filed 2024-04-02 | |
| 2020-12-31 | -$0.28 20-F · filed 2023-03-31 | |
| 2019-12-31 | -$0.72 20-F · filed 2022-03-31 |